Roivant Sciences Ltd. (ROIVW) has a market capitalization of $1.97B and trades at $2.75. The 52-week range is 2.63-2.86.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -11.6, Earnings Per Share (EPS) of $-0.24, annual revenue of $29.05M.
The stock has a beta of 0.00, operates in the Healthcare sector.
